BILLERICA, Mass., Nov. 1, 2012 /PRNewswire/ -- Aushon BioSystems has appointed AH diagnostics as its exclusive distributor in Scandinavia (Sweden, Norway, Finland, Denmark, Iceland), effective November 1, 2012. AH diagnostics will offer Aushon's complete portfolio of Cira™ platform products including Cirascan™, Ciraplex™ and Cirasoft™ products for multiplex ELISAs.
AH diagnostics was established to supply products and services to life science and diagnostic companies in the pharmaceutical, biotech, hospital and academic research fields. The company has operations in Denmark, Sweden, Norway and Finland. AH diagnostics has built its reputation across Scandinavia as a distribution leader in the life science field, representing leading global manufacturers, such as Aushon, providing next-generation tools, technologies, training, applications support, instrument installation, validation, and maintenance support to life science researchers.
"Our goal is to be the supplier of choice for high quality and innovative products, equipment and related support services in Scandinavia within the biotechnology/life science area in selected segments," said Niels Rudiger, Chief Executive Officer, AH diagnostics. "We are excited to add Aushon's innovative Cira™ products that provide a breakthrough solution for scientists in clinical development and translational research who need the combination of multiplexing of protein biomarker analysis with the performance of singleplex ELISAs."
"Aushon's products are an excellent fit with AH diagnostics capabilities. The Cira™ platform offers unrivaled quantitative performance combined with multiplex ELISA analysis of protein biomarkers. We are committed to bring this technology to researchers in Scandinavia in collaboration with AH diagnostics. AH diagnostics has built a strong reputation across Scandinavia for addressing the needs of the life science research community. We look forward to working with them to assist scientists with our products," said Bill Williams, Vice President of Sales at Aushon.
For more information on the Cira™ platform, please visit: www.aushon.com.
Aushon BioSystems, Inc., provides a comprehensive suite of multiplex immunoassay products and services for protein biomarker discovery, development, and analysis to leading pharmaceutical, biotechnology, academic, and diagnostic clients worldwide. Our unique combination of proprietary microarray printing, extensive biomarker content, and our innovative Cira immunoassay platform deliver exceptional performance, quality, and reliability to accelerate preclinical and clinical biomarker research. Our customers, who include nine of the top ten pharmaceutical companies, trust Aushon to supply the most reliable biomarker data available, lowering costs and improving research productivity.
Chief Executive Officer
SOURCE Aushon BioSystems